Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study.

Hirata S, Dirven L, Shen Y, Centola M, Cavet G, Lems WF, Tanaka Y, Huizinga TW, Allaart CF.

Rheumatology (Oxford). 2013 Jul;52(7):1202-7. doi: 10.1093/rheumatology/kes362. Epub 2013 Feb 7.

2.

An evaluation of molecular and clinical remission in rheumatoid arthritis by assessing radiographic progression.

van der Helm-van Mil AH, Knevel R, Cavet G, Huizinga TW, Haney DJ.

Rheumatology (Oxford). 2013 May;52(5):839-46. doi: 10.1093/rheumatology/kes378. Epub 2013 Jan 3.

3.

Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity.

Curtis JR, van der Helm-van Mil AH, Knevel R, Huizinga TW, Haney DJ, Shen Y, Ramanujan S, Cavet G, Centola M, Hesterberg LK, Chernoff D, Ford K, Shadick NA, Hamburger M, Fleischmann R, Keystone E, Weinblatt ME.

Arthritis Care Res (Hoboken). 2012 Dec;64(12):1794-803. doi: 10.1002/acr.21767.

4.

A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational study.

Hirata S, Li W, Defranoux N, Cavet G, Bolce R, Yamaoka K, Saito K, Tanaka Y.

Mod Rheumatol. 2015 May;25(3):344-9. doi: 10.3109/14397595.2014.958893. Epub 2014 Oct 8.

PMID:
25295918
6.

Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study.

Bakker MF, Cavet G, Jacobs JW, Bijlsma JW, Haney DJ, Shen Y, Hesterberg LK, Smith DR, Centola M, van Roon JA, Lafeber FP, Welsing PM.

Ann Rheum Dis. 2012 Oct;71(10):1692-7. doi: 10.1136/annrheumdis-2011-200963. Epub 2012 May 17.

7.

Development of a multi-biomarker disease activity test for rheumatoid arthritis.

Centola M, Cavet G, Shen Y, Ramanujan S, Knowlton N, Swan KA, Turner M, Sutton C, Smith DR, Haney DJ, Chernoff D, Hesterberg LK, Carulli JP, Taylor PC, Shadick NA, Weinblatt ME, Curtis JR.

PLoS One. 2013 Apr 9;8(4):e60635. doi: 10.1371/journal.pone.0060635. Print 2013. Erratum in: PLoS One. 2014;9(6):e99812.

8.

Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis.

Eastman PS, Manning WC, Qureshi F, Haney D, Cavet G, Alexander C, Hesterberg LK.

J Pharm Biomed Anal. 2012 Nov;70:415-24. doi: 10.1016/j.jpba.2012.06.003. Epub 2012 Jun 12.

9.

The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.

Salaffi F, Ciapetti A, Gasparini S, Carotti M, Bombardieri S; New Indices study group.

Clin Exp Rheumatol. 2012 Nov-Dec;30(6):912-21. Epub 2012 Dec 17.

PMID:
22935335
10.

Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.

Hambardzumyan K, Bolce R, Saevarsdottir S, Cruickshank SE, Sasso EH, Chernoff D, Forslind K, Petersson IF, Geborek P, van Vollenhoven RF.

Ann Rheum Dis. 2015 Jun;74(6):1102-9. doi: 10.1136/annrheumdis-2013-204986. Epub 2014 May 8.

11.

Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement.

Wechalekar MD, Lester S, Proudman SM, Cleland LG, Whittle SL, Rischmueller M, Hill CL.

Arthritis Rheum. 2012 May;64(5):1316-22. doi: 10.1002/art.33506.

13.

Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.

Chandrashekara S, Priyanka BU.

Int J Rheum Dis. 2013 Jun;16(3):291-6. doi: 10.1111/1756-185X.12091. Epub 2013 Jun 8.

PMID:
23981750
14.

A multibiomarker disease activity score for rheumatoid arthritis predicts radiographic joint damage in the BeSt study.

Markusse IM, Dirven L, van den Broek M, Bijkerk C, Han KH, Ronday HK, Bolce R, Sasso EH, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

J Rheumatol. 2014 Nov;41(11):2114-9. doi: 10.3899/jrheum.131412. Epub 2014 Aug 15.

15.

Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study.

Hirata S, Saito K, Kubo S, Fukuyo S, Mizuno Y, Iwata S, Nawata M, Sawamukai N, Nakano K, Yamaoka K, Tanaka Y.

Arthritis Res Ther. 2013 Sep 25;15(5):R135. doi: 10.1186/ar4315.

17.

Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort.

Ranganath VK, Yoon J, Khanna D, Park GS, Furst DE, Elashoff DA, Jawaheer D, Sharp JT, Gold RH, Keystone EC, Paulus HE; Western Consortium of Practicing Rheumatologists.

Ann Rheum Dis. 2007 Dec;66(12):1633-40. Epub 2007 May 1.

18.

Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial.

Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, Sharif SK, Vaghef-Mehrabany L, Asghari-Jafarabadi M, Nakhjavani MR, Mohtadi-Nia J.

Int J Rheum Dis. 2014 Jun;17(5):519-27. doi: 10.1111/1756-185X.12333. Epub 2014 Mar 27.

PMID:
24673738
19.

Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis.

Klarenbeek NB, Koevoets R, van der Heijde DM, Gerards AH, Ten Wolde S, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Oct;70(10):1815-21. doi: 10.1136/ard.2010.149260. Epub 2011 Aug 3.

PMID:
21813548
20.

Associations between vitamin D, disease activity, and clinical response to therapy in rheumatoid arthritis.

Baker JF, Baker DG, Toedter G, Shults J, Von Feldt JM, Leonard MB.

Clin Exp Rheumatol. 2012 Sep-Oct;30(5):658-64. Epub 2012 Oct 17.

PMID:
22776409
Items per page

Supplemental Content

Write to the Help Desk